<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320680</url>
  </required_header>
  <id_info>
    <org_study_id>29BRC20.0073</org_study_id>
    <nct_id>NCT04320680</nct_id>
  </id_info>
  <brief_title>Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation</brief_title>
  <acronym>CO LUPUS</acronym>
  <official_title>Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest (
      France)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      all patients coming to the LUPUS multidisciplinary consultation in brest ( France) will have
      a clinical examination, a biological and immunogical blood samples, cutaneous biopsies or
      renal biospies if necessary, an ultrasonographic articular and salivary glandular examination
      if needed. In case of articular involvement, some Xrays ( hands and feet) will be done at the
      inclusion and during the follow up each year during 5 years .
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>diagnosis and follow up of a lupus cohort</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cohort lupus: epidemiologic lupus study about diagnosis and follow up</measure>
    <time_frame>five years</time_frame>
    <description>epidemiologic lupus study in collecting data ( description of the population, biologic and immunologic data collection, data of articular damges with xrays datas) about Diagnosis and follow up of a cohort lupus in a multidisciplibnary consultation in brest hospital ( France).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>lupus cohort follow up</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>it is a descrption lupus patients study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>description of a lupus patient cohort</intervention_name>
    <description>description of a lupus patient cohort</description>
    <arm_group_label>lupus cohort follow up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women or men, more than 18 years old, coming to the multidisciplinary consultation in
             brest ( France).

          -  With written consentment

        Exclusion Criteria:

          -  patients less than 18 years old

          -  refusing to participate

          -  Under legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>sandrine jousse joulin, MD</last_name>
    <phone>+33 2 98 34 72 68</phone>
    <email>sandrine.jousse-oulin@chu-brest.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>alain saraux, MD, PHD</last_name>
    <phone>+33 2 98 347270</phone>
    <email>alain.saraux@chu-brest.fr</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cutaneous lupus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

